MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
452.21%
Quick Ratio
377.19%
Cash Ratio
192.75%
Debt to Asset Ratio
22.66%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Goodwill
Property, plant, and equipment, ...
Others
Liabilities Breakdown
Total edwards lifesciences corpo...
Total current liabilities
Long-term debt
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
2,906,500
2,445,500
2,938,000
2,685,600
Short-term investments (note 5)
1,346,200
1,226,000
1,288,300
1,156,400
Accounts receivable, net of allowances of 16.0 and 15.0, respectively
770,400
775,700
659,600
693,300
Other receivables
185,300
197,300
252,500
199,500
Inventories (note 2)
1,131,200
1,119,000
1,126,200
1,140,900
Prepaid expenses
119,000
135,700
135,000
125,200
Other current assets
360,300
329,500
339,300
323,400
Current assets of discontinued operations (note 5)
-
-
0
34,600
Total current assets
6,818,900
6,228,700
6,738,900
6,358,900
Long-term investments (note 5)
244,100
285,600
278,600
274,700
Property, plant, and equipment, net
1,841,800
1,823,100
1,811,900
1,743,300
Operating lease right-of-use assets
100,300
99,300
102,700
96,500
Goodwill
1,951,200
1,819,600
1,768,600
1,768,500
Other intangible assets, net
1,382,600
1,227,900
1,128,200
1,130,800
Deferred income taxes
911,800
1,098,100
1,138,100
1,099,900
Other assets (note 2)
616,400
738,900
730,200
784,800
Non-current assets of discontinued operations (note 5)
-
-
0
14,800
Total assets
13,867,100
13,321,200
13,697,200
13,272,200
Accounts payable
210,500
181,100
227,500
165,000
Accrued and other liabilities (note 2)
1,273,300
1,203,600
1,561,700
1,393,900
Operating lease liabilities
24,100
24,300
24,500
26,800
Current liabilities of discontinued operations (note 5)
-
-
0
2,300
Total current liabilities
1,507,900
1,409,000
1,813,700
1,588,000
Long-term debt
598,700
598,500
598,300
598,200
Operating lease liabilities
81,600
80,100
82,600
75,300
Uncertain tax positions
572,200
555,400
502,700
442,900
Litigation settlement accrual
-
-
0
-
Other liabilities
381,800
350,700
362,300
362,600
Non-current liabilities of discontinued operations (note 4)
-
-
-
200
Total liabilities
3,142,200
2,993,700
3,359,600
3,067,200
Additional paid-in capital
2,975,900
2,781,500
2,768,400
2,697,400
Retained earnings
14,863,100
14,621,200
14,240,500
14,149,300
Accumulated other comprehensive loss (note 13)
-214,600
-221,300
-238,300
-250,400
Treasury stock, at cost, 85.1 and 78.0 shares, respectively
7,668,100
7,513,900
7,091,700
7,049,500
Total edwards lifesciences corporation stockholders' equity
10,618,000
10,327,500
10,337,600
10,205,000
Noncontrolling interest
106,900
-
0
0
Total stockholders' equity
10,724,900
-
10,337,600
10,205,000
Total liabilities and equity
13,867,100
13,321,200
13,697,200
13,272,200
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$2,906,500K
(-11.19%↓ Y/Y)
Short-term investments
(note 5)
$1,346,200K
(70.53%↑ Y/Y)
Inventories (note 2)
$1,131,200K
(-0.92%↓ Y/Y)
Accounts receivable, net
of allowances of...
$770,400K
(10.53%↑ Y/Y)
Other current assets
$360,300K
(14.60%↑ Y/Y)
Other receivables
$185,300K
(-9.87%↓ Y/Y)
Prepaid expenses
$119,000K
(8.18%↑ Y/Y)
Total current assets
$6,818,900K
(3.67%↑ Y/Y)
Goodwill
$1,951,200K
(9.82%↑ Y/Y)
Property, plant, and
equipment, net
$1,841,800K
(6.67%↑ Y/Y)
Other intangible
assets, net
$1,382,600K
(17.89%↑ Y/Y)
Deferred income taxes
$911,800K
(-15.74%↓ Y/Y)
Other assets (note 2)
$616,400K
(-17.04%↓ Y/Y)
Long-term investments
(note 5)
$244,100K
(-18.22%↓ Y/Y)
Operating lease
right-of-use assets
$100,300K
(1.31%↑ Y/Y)
Total assets
$13,867,100K
(2.81%↑ Y/Y)
Total liabilities and
equity
$13,867,100K
(2.81%↑ Y/Y)
Total stockholders'
equity
$10,724,900K
(1.12%↑ Y/Y)
Total liabilities
$3,142,200K
(9.02%↑ Y/Y)
Total edwards
lifesciences corporation...
$10,618,000K
(0.69%↑ Y/Y)
Noncontrolling interest
$106,900K
(74.67%↑ Y/Y)
Total current
liabilities
$1,507,900K
(7.35%↑ Y/Y)
Long-term debt
$598,700K
(0.12%↑ Y/Y)
Uncertain tax positions
$572,200K
(35.72%↑ Y/Y)
Other liabilities
$381,800K
(0.69%↑ Y/Y)
Operating lease
liabilities
$81,600K
(3.68%↑ Y/Y)
Treasury stock, at cost,
85.1 and 78.0 shares,...
$7,668,100K
(18.77%↑ Y/Y)
Accumulated other
comprehensive loss (note 13)
-$214,600K
(18.74%↑ Y/Y)
Retained earnings
$14,863,100K
(7.25%↑ Y/Y)
Accrued and other
liabilities (note 2)
$1,273,300K
(4.85%↑ Y/Y)
Accounts payable
$210,500K
(29.86%↑ Y/Y)
Operating lease
liabilities
$24,100K
(-6.95%↓ Y/Y)
Additional paid-in capital
$2,975,900K
(8.21%↑ Y/Y)
something is missing
$661,700K
Buy us a coffee
logo (34)-svg
Edwards Lifesciences Corp (EW)
logo (34)-svg
Edwards Lifesciences Corp (EW)